ten Freyhaus Henrik, Huntgeburth Michael, Wingler Kirstin, Schnitker Jessika, Bäumer Anselm T, Vantler Marius, Bekhite Mohamed M, Wartenberg Maria, Sauer Heinrich, Rosenkranz Stephan
Klinik III für Innere Medizin der Universität zu Köln, Germany.
Cardiovasc Res. 2006 Jul 15;71(2):331-41. doi: 10.1016/j.cardiores.2006.01.022. Epub 2006 Mar 20.
Reactive oxygen species (ROS) produced by NAD(P)H oxidases (Nox) play a significant role in the pathophysiology of cardiovascular diseases. Expression and activity of NAD(P)H oxidases are regulated by growth factors such as angiotensin II and platelet-derived growth factor (PDGF). We characterized the effects of the novel Nox inhibitor VAS2870 on PDGF-dependent ROS liberation and cellular events in vascular smooth muscle cells (VSMC).
PDGF-BB increased NAD(P)H oxidase activity (lucigenin-enhanced chemiluminescence) and intracellular ROS levels (detected by confocal laserscanning microscopy using 2,7-DCF) to 229+/-9% and 362+/-54% at 1 and 2 h, respectively. Preincubation with VAS2870 (10 and 20 microM) completely abolished PDGF-mediated NAD(P)H oxidase activation and ROS production. Since ROS are involved in various growth factor-induced cellular functions, the influence of VAS2870 on PDGF-induced DNA synthesis and chemotaxis was determined. PDGF promoted a 4.2+/-0.2-fold increase of VSMC migration (modified Boyden chamber, p<0.01) and increased DNA synthesis by maximally 3.2+/-0.4-fold (BrdU incorporation, p<0.01) in a concentration-dependent manner. Preincubation with VAS2870 (0.1-20 microM) did not affect PDGF-induced cell cycle progression. However, it abolished PDGF-dependent chemotaxis of VSMC in a concentration-dependent manner (100% inhibition at 10 microM). These findings were related to PDGF-dependent signaling events. Western blot analyses using phospho-specific antibodies revealed that the downstream signaling molecules Akt, Erk, and Src were activated by PDGF. However, VAS2870 blocked PDGF-dependent activation of Src, but not of Akt and Erk, in a concentration-dependent manner.
VAS2870 effectively suppresses growth factor-mediated ROS liberation in VSMC. Furthermore, it completely inhibits PDGF-dependent VSMC migration, whereas it does not affect DNA synthesis. These divergent effects reflect the critical role of Src activity, which-in contrast to Akt and Erk-appears to be redox-sensitive and is absolutely required for PDGF-induced chemotaxis, but not cell cycle progression.
烟酰胺腺嘌呤二核苷酸磷酸(NAD(P)H)氧化酶(Nox)产生的活性氧(ROS)在心血管疾病的病理生理学中起重要作用。NAD(P)H氧化酶的表达和活性受血管紧张素II和血小板衍生生长因子(PDGF)等生长因子的调节。我们研究了新型Nox抑制剂VAS2870对血管平滑肌细胞(VSMC)中PDGF依赖性ROS释放和细胞事件的影响。
PDGF-BB分别在1小时和2小时时将NAD(P)H氧化酶活性(虫荧光素增强化学发光)和细胞内ROS水平(使用2,7-二氯荧光素通过共聚焦激光扫描显微镜检测)提高到229±9%和362±54%。用VAS2870(10和20 microM)预孵育完全消除了PDGF介导的NAD(P)H氧化酶激活和ROS产生。由于ROS参与各种生长因子诱导的细胞功能,因此确定了VAS2870对PDGF诱导的DNA合成和趋化性的影响。PDGF以浓度依赖性方式促进VSMC迁移增加4.2±0.2倍(改良Boyden小室,p<0.01),并使DNA合成最大增加3.2±0.4倍(BrdU掺入,p<0.01)。用VAS2870(0.1 - 20 microM)预孵育不影响PDGF诱导的细胞周期进程。然而,它以浓度依赖性方式消除了VSMC的PDGF依赖性趋化性(在10 microM时100%抑制)。这些发现与PDGF依赖性信号事件有关。使用磷酸化特异性抗体的蛋白质印迹分析显示,下游信号分子Akt、Erk和Src被PDGF激活。然而,VAS2870以浓度依赖性方式阻断了PDGF依赖性Src激活,但不影响Akt和Erk激活。
VAS2870有效抑制VSMC中生长因子介导的ROS释放。此外,它完全抑制PDGF依赖性VSMC迁移,而不影响DNA合成。这些不同的作用反映了Src活性的关键作用,与Akt和Erk不同,Src活性似乎对氧化还原敏感,并且是PDGF诱导的趋化性而非细胞周期进程所绝对必需的。